Protease receptor antagonism to target blood platelet therapies.
about
Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets.Bioinnovation Enterprise: An engine driving breakthrough therapies.Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
P2860
Protease receptor antagonism to target blood platelet therapies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Protease receptor antagonism to target blood platelet therapies.
@en
type
label
Protease receptor antagonism to target blood platelet therapies.
@en
prefLabel
Protease receptor antagonism to target blood platelet therapies.
@en
P2860
P356
P1476
Protease receptor antagonism to target blood platelet therapies.
@en
P2093
P2860
P356
10.1002/CPT.282
P407
P577
2015-10-26T00:00:00Z